Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study

Ajeganova S, Andersson M, Forslind K, Gjertsson I, Nyhäll-Wåhlin BM, Svensson B, Hafström I (2023) Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years. BMC Rheumatol 7:23

Article  PubMed  PubMed Central  Google Scholar 

Buttgereit F, Palmowski A, Bond M, Adami G, Dejaco C (2024) Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nat Rev Rheumatol 20:417–431

Article  PubMed  Google Scholar 

Amkreutz J, de Moel EC, Theander L et al (2021) Association between bone mineral density and autoantibodies in patients with rheumatoid arthritis. Arthritis Rheumatol 73:921–930

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bugatti S, Bogliolo L, Manzo A, De Stefano L, Delvino P, Motta F, Montecucco C (2021) Impact of anti-citrullinated protein antibodies on progressive systemic bone mineral density loss in patients with early rheumatoid arthritis after two years of treat-to-target. Front Immunol 12:701922

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu SF, Chen JF, Chen YC, Wang YW, Hsu CY, Lai HM, He HR, Ko CH, Chiu WC, Cheng TT (2022) The impact of seropositivity on systemic bone loss in rheumatoid arthritis-a 3-year interim analysis of a longitudinal observational cohort study. Front Med (Lausanne) 9:885801

Article  PubMed  PubMed Central  Google Scholar 

Broy SB, Tanner SB (2011) Official positions for FRAX® clinical regarding rheumatoid arthritis from joint official positions development conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom 14:184–189

Article  PubMed  Google Scholar 

Smolen JS, Landewé RBM, Bergstra SA et al (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 82:3–18

Article  CAS  PubMed  Google Scholar 

Abtahi S, Cordtz R, Dreyer L, Driessen JHM, Boonen A, Burden AM (2022) Biological disease-modifying antirheumatic drugs and osteoporotic fracture risk in patients with rheumatoid arthritis: a Danish cohort study. Am J Med 135:879-888.e873

Article  CAS  PubMed  Google Scholar 

Tronstad I, Hoff M, Horn J, Vikjord SAA, Videm V, Johansson J, Nilsen TIL, Langhammer A (2024) Rheumatoid arthritis, disease-modifying antirheumatic drugs and risk of major osteoporotic fracture: prospective data from the HUNT Study, Norway. RMD Open. https://doi.org/10.1136/rmdopen-2023-003919

Article  PubMed  PubMed Central  Google Scholar 

Chen JF, Hsu CY, Yu SF, Ko CH, Chiu WC, Lai HM, Chen YC, Su YJ, Cheng TT (2020) The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis. Rheumatology (Oxford) 59:2471–2480

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen TL, Chang KH, Su KY (2022) Effects of biological/targeted therapies on bone mineral density in inflammatory arthritis. Int J Mol Sci. https://doi.org/10.3390/ijms23084111

Article  PubMed  PubMed Central  Google Scholar 

Hamar A, Szekanecz Z, Pusztai A et al (2021) Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis. Osteoporos Int 32:1621–1629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pawar A, Desai RJ, He M, Bessette L, Kim SC (2021) Comparative risk of nonvertebral fractures among patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs. ACR Open Rheumatol 3:531–539

Article  PubMed  PubMed Central  Google Scholar 

Shin DW, Cho J, Park JH, Cho B (2022) National general health screening program in Korea: history, current status, and future direction. Precis Future Med 6:9–31

Article  Google Scholar 

Cho MH, Cho JH, Eun Y et al (2024) Rheumatoid arthritis and risk of lung cancer: a nationwide cohort study. J Thorac Oncol 19:216–226

Article  PubMed  Google Scholar 

Cho SK, Sung YK, Choi CB, Kwon JM, Lee EK, Bae SC (2013) Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. Rheumatol Int 33:2985–2992

Article  PubMed  Google Scholar 

Chung C, Kim H, Han K, Jung J, Eun Y, Lee H, Park J, Shin DW, Lee SW (2024) Does rheumatoid arthritis increase the risk of COPD?: a nationwide retrospective cohort study. Chest 165:1362–1371

Article  CAS  PubMed  Google Scholar 

Kang J, Eun Y, Jang W, Cho MH, Han K, Jung J, Kim Y, Kim GT, Shin DW, Kim H (2023) Rheumatoid arthritis and risk of Parkinson disease in Korea. JAMA Neurol 80:634–641

Article  PubMed  PubMed Central  Google Scholar 

Kim H, Sung YK (2021) Epidemiology of rheumatoid arthritis in Korea. J Rheum Dis 28:60–67

Article  PubMed  PubMed Central  Google Scholar 

Cho H, Park J, Kim B, Han K, Choi HL, Shin DW (2024) Increased risk of fracture after traumatic amputation: a nationwide retrospective cohort study. Healthcare (Basel). https://doi.org/10.3390/healthcare12131362

Article  PubMed  PubMed Central  Google Scholar 

Kim S, Kim B, Han KD, Park J, Yoo JE, Choi HL, Chang WH, Cho IY, Shin DW (2024) Risk of fracture among patients with spinal cord injury: a nationwide cohort study in South Korea. Bone 183:117093

Article  PubMed  Google Scholar 

Koo HY, Cho EB, Kong SH, Han K, Lee KN, Yoo JE, Min JH, Chun S, Shin DW (2023) Fracture risk in Parkinson’s disease according to its severity and duration. Osteoporos Int 34:81–89

Article  CAS  PubMed  Google Scholar 

Hsu CY, Chen JF, Su YJ, Chen YC, Lai HM, Yu SF, He HR, Cheng TT (2020) Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes. Ther Adv Chronic Dis 11:2040622320981517

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung GE, Cho EJ, Kim MJ et al (2023) Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study. Front Endocrinol (Lausanne) 14:1156996

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization (2000) International association for the study of obesity, international obesity task force. The Asia-Pacific perspective: Redefining obesity and its treat ment. Health Communications Australia, Sydney. https://iris.who.int/bitstream/handle/10665/206936/0957708211_eng.pdf

Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96:e6983

Article  PubMed  PubMed Central  Google Scholar 

Theander L, Jacobsson LTH, Turesson C (2023) Osteoporosis-related fractures in men and women with established and early rheumatoid arthritis: predictors and risk compared with the general population. BMC Rheumatol 7:28

Article  PubMed  PubMed Central  Google Scholar 

Theander L, Sharma A, Karlsson MK, Åkesson KE, Jacobsson LTH, Turesson C (2024) Risk and predictors of fractures in early rheumatoid arthritis - a long term follow up study of an inception cohort. Semin Arthritis Rheum 68:152497

Article  PubMed  Google Scholar 

Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, Cai J, Rose P, Mao J, Zhu YZ (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther 8:68

Article  PubMed  PubMed Central  Google Scholar 

Pietschmann P, Butylina M, Kerschan-Schindl K, Sipos W (2022) Mechanisms of systemic osteoporosis in rheumatoid arthritis. Int J Mol Sci. https://doi.org/10.3390/ijms23158740

Article  PubMed  PubMed Central  Google Scholar 

Steffen U, Schett G, Bozec A (2019) How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol 10:1483

Comments (0)

No login
gif